Journal
DERMATOLOGIC THERAPY
Volume 34, Issue 1, Pages -Publisher
WILEY-HINDAWI
DOI: 10.1111/dth.14669
Keywords
alopecia; apremilast; atopic dermatitis; bimatoprost; crisaborole; cutaneous disorders; dermatology; hair growth; latanoprost; phosphodiesterase inhibitors; prostaglandin analogues; psoriasis; vitiligo
Categories
Ask authors/readers for more resources
Medicines with immunomodulatory and anti-inflammatory effects can be used to treat various dermatologic diseases, with phosphodiesterase inhibitors and prostaglandin analogues being commonly employed. These medications have shown to be safe and effective in treating different skin disorders, highlighting their value in dermatologic applications.
Due to immune-mediated nature, medicines with immunomodulatory and anti-inflammatory effects can used to treat many dermatologic diseases. Phosphodiesterase and prostaglandins are involved in many inflammatory pathways that cause cutaneous disorders. Phosphodiesterase inhibitors (PDEIs) and prostaglandin analogues are currently employed to treat several dermatologic disorders. Given the few comprehensive reviews in this context, focusing on the dermatologic applications and efficacy of these medicines appears valuable. The present comprehensive review was, therefore, performed on the applications of PDEIs and prostaglandin analogues in different cutaneous disorders. All the relevant articles were selected to perform this review by searching databases such as Medline, Google Scholar, Scopus, and Web of Science. Oral PDEIs, especially apremilast, is an effective medicine in psoriasis and a number of other cutaneous disorders such as vitiligo. Topical PDEIs, including crisaborole ointment 2%, is a safe and effective treatment in atopic dermatitis. Prostaglandin analogues, especially their topical forms such as latanoprost and bimatoprost, have different applications in cutaneous disorders, including pigmentary disorders, especially vitiligo and hair repigmentation; for instance, bimatoprost is used for eyelash repigmentation. Prostaglandin analogues are also used in alopecia, including androgenetic alopecia and alopecia areata. Oral (apremilast) and topical (crisaborole) PDEIs and topical prostaglandin analogues, including latanoprost and bimatoprost, were found safe and effective in different skin diseases. In terms of efficiency and safety, these medicines compete with other medications of similar use even with higher efficacy and fewer side effects that necessitate further studies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available